← Back to medicines

Plasmafil 6%+0.9% is a Product of the Generic Hydroxyethyl Starch + Sodium Chloride

Plasmafil 6%+0.9% belongs to the generic category of Hydroxyethyl Starch + Sodium Chloride. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Plasmafil 6%+0.9%. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Hydroxyethyl Starch + Sodium Chloride and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Medicine Image
OTC

*Up to 10% Discount

(Depends on pharmacy)

Plasmafil 6%+0.9%

Opsonin Pharma Ltd. · IV Infusion

Generic

Hydroxyethyl Starch + Sodium Chloride

Strength6%+0.9%
Unit Price
654

/ 500 ml bottle

Order Now

Description of Plasmafil 6%+0.9%

Plasmafil 6%+0.9% may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Plasmafil 6%+0.9% is provided below to help users gain a clear understanding of this medicine.

What Is Plasmafil 6%+0.9% Indications and Uses?

This preparation is indicated for the treatment and prophylaxis of hypovolemia in adults and children. It is not a substitute for red blood cells or coagulation factors in plasma.


Pharmacology (Source, Chemical and Physical Composition) Of Plasmafil 6%+0.9%

Expansol (6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium Chloride IV infusion) is a clear to slightly opalescent, colorless to slightly yellow, sterile, non-pyrogenic, isotonic solution. The chemical name of Hydroxyethyl Starch is poly (O-2-hydroxyethyl) starch. Expansol contains Hydroxyethyl Starch in a colloidal solution which expands plasma volume when administered intravenously.


Dosage And Administration of Plasmafil 6%+0.9%

Hydroxyethyl Starch is administered by intravenous infusion only. The daily dose and rate of infusion depend on the patient’s blood loss, on the maintenance or restoration of hemodynamics and on the hemodilution. Hydroxyethyl starchcan be administered repetitively over several days.The initial 10 to 20 mL should be infused slowly, keeping the patient under close observation due to possible anaphylactoid reactions.Adult Dose: Infusions up to 33 ml of Expansol per kg of body weight per day are most commonly used. There is a limited experience with infusions between 33 ml/kg/day and 50 ml/kg/day.Pediatric Dose: Average 16±9 ml of Expansol per kg of body weight per day. The dosage in children should be adapted to the individual patient colloid needs, taking into account the disease state, as well as the hemodynamic and hydration status


Drug Interactions of Plasmafil 6%+0.9%

No interactions with other drugs or nutritional products are known.


Side Effects of Plasmafil 6%+0.9%

Most common adverse reactions (incidence >1%) are pruritus, elevated serum amylase, hemodilution. Anaphylactoid/hypersensitivity reactions can occur


Use During Pregnancy and Lactation

There are no adequate and well-controlled studies in pregnant women. Hydroxyethyl starch should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk.


Precautions And Warnings for Plasmafil 6%+0.9%

Anaphylactoid Reactions: Anaphylactoid reactions (mild influenza-like symptoms, bradycardia, tachycardia, bronchospasm, non-cardiac pulmonary edema) have been reported with solutions containing hydroxyethyl starch. If a hypersensitivity reaction occurs, administration of the drug should be discontinued immediately and the appropriate treatment and supportive measures should be undertaken until symptoms have resolved.Renal Dysfunction: Avoid use in patients with pre-existing renal dysfunction. Discontinue use of Expansol at the first sign of renal injury. Continue to monitor renal function in hospitalized patients for at least 90 days.Coagulopathy: Monitor the coagulation status of patients undergoing open heart surgery in association with cardiopulmonary bypass as excess bleeding has been reported with Hydroxyethyl Starch solutions in this population. Discontinue use of Expansol at the first sign of coagulopathy.Fluid Equilibrium: Avoid fluid overload; adjust dosage in patients with cardiac or renal dysfunction. Fluid status and rate of infusion should be assessed regularly during treatment, especially in patients with cardiac insufficiency or severe kidney dysfunction. In cases of severe dehydration, a crystalloid solution should be given first. Generally, sufficient fluid should be administered in order to avoid dehydration.Monitoring: Laboratory Tests: Clinical evaluation and periodic laboratory determinations are necessary to monitor fluid balance, serum electrolyte concentrations, kidney function, acid-base balance, and coagulation parameters during prolonged parenteral therapy. Monitor liver function in patients receiving Hydroxyethyl Starch products.


Therapeutic Class

Plasma expanders


Storage Conditions of It

Keep this medicine out of the sight and reach of children. Do not freeze. Do not store above 25°C.

Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.

Alternative Medicines

⚠ Disclaimer

The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

allsomadhan logo

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"

Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved

DBID

Registration ID: 176322642

Trade License: TRAD/DNCC/040904/2023

Payment Methods
google play storeapple store
Chat with us